Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.52 |
| ▸ | ATIC | P31939 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 10/20 | 0.52 |
| ▸ | CA1 | P00915 | 9/20 | 0.52 |
| ▸ | CA9 | Q16790 | 9/20 | 0.50 |
| ▸ | CA12 | O43570 | 8/20 | 0.50 |
| ▸ | CA4 | P22748 | 5/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.50 |
| ▸ | CA6 | P23280 | 4/20 | 0.48 |
| ▸ | CA5A | P35218 | 4/20 | 0.48 |
| ▸ | CA7 | P43166 | 4/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 4/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1804799 | 0.85 | LMNA (0.58) | LMNAHSD17B10CYP2C9CYP2C19CA2 | |
| SCHEMBL157169 | 0.84 | ALDH1A1 (0.62) | HSD17B10CYP2C9CYP2C19ATICMEN1 | |
| SCHEMBL29518641 | 0.84 | ALDH1A1 (0.62) | HSD17B10CYP2C9CYP2C19ATICMEN1 | |
| SCHEMBL3246905 | 0.84 | HSD17B10 (0.51) | LMNAHSD17B10CYP2C9CYP2C19ATIC | |
| SCHEMBL28471752 | 0.84 | HSD17B10 (0.51) | LMNAHSD17B10CYP2C9CYP2C19ATIC | |
| SCHEMBL4311014 | 0.84 | HSD17B10 (0.51) | LMNAHSD17B10CYP2C9CYP2C19ATIC | |
| SCHEMBL29941351 | 0.84 | ALDH1A1 (0.62) | HSD17B10CYP2C9CYP2C19ATICMEN1 | |
| SCHEMBL28471751 | 0.82 | ALDH1A1 (0.60) | HSD17B10CYP2C9CYP2C19ATICMEN1 | |
| SCHEMBL3246907 | 0.82 | ALDH1A1 (0.60) | HSD17B10CYP2C9CYP2C19ATICMEN1 | |
| Water SCHEMBL7704455 | 0.82 | ALDH1A1 (0.60) | HSD17B10CYP2C9CYP2C19ATICMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1994385-B1 | CHANGED CONDITION INDICATOR | COOPERMAN ISADORE (US) | 2019-08-14 | — | — | EP | disclosed |
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
| US-7770534-B2 | Changed condition indicator | THERMOPROX | 2010-08-10 | — | — | US | disclosed |
| EP-1994385-A2 | CHANGED CONDITION INDICATOR | Cooperman, Isadore (US) | 2008-11-26 | — | — | EP | disclosed |
| US-7338963-B2 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-03-04 | — | — | US | disclosed |
| US-7338963-B2 | Lactam-containing compounds and derivatives thereof as factor Xa inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2008-03-04 | — | — | US | disclosed |
| WO-2007106463-A2 | CHANGED CONDITION INDICATOR | COOPERMAN ISADORE (US) | 2007-09-20 | — | — | WO | disclosed |
| US-20070151502-A1 | Changed condition indicator | THERMOPROX | 2007-07-05 | — | — | US | disclosed |
| US-5530105-A | INK JET PRINTING | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1996-06-25 | — | — | US | disclosed |
| EP-0645436-A1 | Tetrakisazo compound and ink containing the compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1995-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | LMNA 1431/4885HSD17B10 2848/4885CYP2C9 692/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.